Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in Chinese patients with aplastic anemia and liver injury
ChiCTR2100050045Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of avatrombopag in aplastic anemia, sponsored by Tianjin Medical University General Hospital. Primary endpoint: Hematological response. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
avatrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on ChiCTR2100050045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050045.